Shares of regenerative medicine stem cell companies are reacting to visibility and sentiment issues as stocks are acting as a thermometer of investor emotion. Read more…
Shares of regenerative medicine stem cell companies are suffering from the summer doldrums and lack of attention Read more…
Shares of regenerative medicine stem cell companies have been laggard during negative market gyrations Read more…
Shares of regenerative medicine stem cell companies were AGAIN off due to macro issues and negative market gyrations. Read more…
Shares of regenerative medicine stem cell companies were off due to macro issues and negative government data. Read more…
Shares of regenerative medicine stem cell companies were off due to lack of attention of a holiday weekend by Friday, 5/27/11. Read more…
Shares of regenerative medicine stem cell companies were again …pummeled by depreciating markets by Friday, 5/20/11. Read more…
Shares of regenerative medicine stem cell companies were pummeled hit by depreciating markets and profit taking by Friday, 5/13/11. Read more…
Shares of regenerative medicine stem cell companies gyrated by low volumes and earnings by Friday, 5/6/11, after being excruciatingly pushed way down and some up during the week. Read more…
Shares of regenerative medicine stem cell companies were gyrated by low volumes by Friday, 4/29/11, after being pushed up and down during the week. Read more…
Founder and Director of Research, Henry McCusker enters his tenth (10) year at Scimitar Equity with past experience in sell-side analysis, buy-side management, corporate management and due diligence.